Sign in

CIK 0001540159

  • Non-accelerated filer
  • Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 905-475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-27 MacDonald Sean Arthur Director Grant or award +19,000 41,054
2025-05-29 MacDonald Sean Arthur Director Grant or award +20,001 22,054
2023-07-20 MacDonald Sean Arthur Director Grant or award · Share Option (right to buy) +20,000 20,000
2023-07-20 MacDonald Sean Arthur Director Grant or award · Share Option (right to buy) +20,000 20,000
2022-02-28 MacDonald Sean Arthur Director Grant or award · Stock Option (right to buy) +11,000 11,000
2021-04-22 MacDonald Sean Arthur Director Grant or award · Stock Option (right to buy) +20,000 20,000
2020-10-13 MacDonald Sean Arthur Director Grant or award · Stock option (right to buy) +20,000 20,000
2020-02-12 MacDonald Sean Arthur Director Grant or award · Share Option (Right to Buy) +11,389 11,389
2019-07-26 MacDonald Sean Arthur Director Grant or award +786 14,369
2019-06-07 MacDonald Sean Arthur Director Grant or award +13,583 13,583

Page 1 of 1 · 10 trades